You are here
,

Bristol-Myers' Opdivo fails late-stage brain cancer trial

  • Friday, 10 May 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in patients with an aggressive form of tumor that affects the brain or the spine.


from Reuters: Health News https://reut.rs/2VbI85V

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply